Nuvalent Inc-a
(NUVL)
|
7.5 |
$376M |
|
19M |
19.44 |
Glaukos Corp Note 2.750% 6/1 (Principal)
|
7.1 |
$356M |
|
272M |
1.31 |
Aerie Pharmaceuticals Note 1.500%10/0 (Principal)
|
3.4 |
$171M |
|
174M |
0.98 |
Invitae Corp Note 2.000% 9/0 (Principal)
|
3.2 |
$162M |
|
207M |
0.78 |
Neurocrine Biosciences
(NBIX)
|
3.2 |
$161M |
|
1.5M |
106.21 |
Adapthealth Corp Common Stock
(AHCO)
|
3.1 |
$154M |
|
8.2M |
18.78 |
Sarepta Therapeutics DBCV 1.500%11/1 (Principal)
|
3.0 |
$148M |
|
89M |
1.67 |
Ionis Pharmaceuticals Note 4/0 (Principal)
|
2.6 |
$129M |
|
128M |
1.01 |
Tabula Rasa Healthcare Note 1.750% 2/1 (Principal)
|
2.3 |
$116M |
|
145M |
0.80 |
Silk Road Medical Inc Common
|
2.3 |
$114M |
|
2.5M |
45.00 |
Caremax Com Cl A
|
2.2 |
$113M |
|
16M |
7.09 |
Apellis Pharmaceuticals Note 3.500% 9/1 (Principal)
|
2.0 |
$99M |
|
52M |
1.91 |
Gilead Sciences
(GILD)
|
1.9 |
$95M |
|
1.5M |
61.69 |
Iveric Bio
|
1.9 |
$94M |
|
5.2M |
17.94 |
Nuvasive Note 1.000% 6/0 (Principal)
|
1.9 |
$94M |
|
97M |
0.97 |
Viatris
(VTRS)
|
1.8 |
$91M |
|
11M |
8.52 |
Biogen Idec
(BIIB)
|
1.8 |
$88M |
|
330k |
267.00 |
Alphatec Hldgs Note 0.750% 8/0 (Principal)
|
1.6 |
$81M |
|
100M |
0.81 |
Intercept Pharmaceuticals In Note 3.500% 2/1 (Principal)
|
1.6 |
$81M |
|
79M |
1.03 |
Pacira Biosciences Note 0.750% 8/0 (Principal)
|
1.6 |
$81M |
|
82M |
0.99 |
Accolade Note 0.500% 4/0 (Principal)
|
1.6 |
$79M |
|
105M |
0.75 |
Aerie Pharmaceuticals
|
1.5 |
$74M |
|
4.9M |
15.13 |
Insmed Note 1.750% 1/1 (Principal)
|
1.5 |
$73M |
|
75M |
0.98 |
ImmunoGen
|
1.3 |
$66M |
|
14M |
4.78 |
Guardant Health Note 11/1 (Principal)
|
1.3 |
$65M |
|
89M |
0.73 |
Catalyst Pharmaceutical Partners
(CPRX)
|
1.3 |
$63M |
|
4.9M |
12.83 |
Pulmonx Corp
(LUNG)
|
1.2 |
$62M |
|
3.7M |
16.66 |
Revolution Medicines
(RVMD)
|
1.1 |
$57M |
|
2.9M |
19.72 |
Intercept Pharmaceuticals In Note 3.250% 7/0 (Principal)
|
1.1 |
$56M |
|
58M |
0.97 |
Larimar Therapeutics
(LRMR)
|
1.1 |
$54M |
|
17M |
3.20 |
Oak Str Health Note 3/1
|
1.0 |
$53M |
|
68M |
0.77 |
Natera Note 2.250% 5/0 (Principal)
|
1.0 |
$51M |
|
38M |
1.37 |
Merus N V
(MRUS)
|
1.0 |
$51M |
|
2.5M |
20.03 |
Nanostring Technologies Note 2.625% 3/0 (Principal)
|
1.0 |
$49M |
|
58M |
0.84 |
Deciphera Pharmaceuticals
|
0.9 |
$46M |
|
2.5M |
18.50 |
Hillevax
(HLVX)
|
0.9 |
$45M |
|
2.7M |
17.09 |
Cogent Biosciences
(COGT)
|
0.9 |
$44M |
|
3.0M |
14.92 |
Evolus
(EOLS)
|
0.9 |
$43M |
|
5.4M |
8.05 |
Mirum Pharmaceuticals
(MIRM)
|
0.8 |
$43M |
|
2.0M |
21.01 |
Livongo Health Note 0.875% 6/0 (Principal)
|
0.8 |
$42M |
|
50M |
0.84 |
Nevro Corp Note 2.750% 4/0 (Principal)
|
0.8 |
$40M |
|
42M |
0.94 |
Cytokinetics Com New
(CYTK)
|
0.8 |
$39M |
|
813k |
48.45 |
1life Healthcare Note 3.000% 6/1 (Principal)
|
0.8 |
$39M |
|
41M |
0.97 |
Edgewise Therapeutics
(EWTX)
|
0.8 |
$39M |
|
3.9M |
9.84 |
Ptc Therapeutics Note 1.500% 9/1 (Principal)
|
0.7 |
$38M |
|
32M |
1.17 |
Anaptysbio Inc Common
(ANAB)
|
0.7 |
$37M |
|
1.5M |
25.51 |
Brookdale Senior Living
(BKD)
|
0.7 |
$37M |
|
8.7M |
4.27 |
Centene Corporation
(CNC)
|
0.7 |
$36M |
|
464k |
77.81 |
Amedisys
(AMED)
|
0.7 |
$35M |
|
360k |
96.79 |
Phreesia
(PHR)
|
0.7 |
$35M |
|
1.4M |
25.48 |
Bellus Health Com New
|
0.6 |
$33M |
|
3.1M |
10.56 |
Kura Oncology
(KURA)
|
0.6 |
$30M |
|
2.2M |
13.66 |
Phathom Pharmaceuticals
(PHAT)
|
0.5 |
$27M |
|
2.4M |
11.08 |
Ideaya Biosciences
(IDYA)
|
0.5 |
$26M |
|
1.7M |
14.92 |
Verve Therapeutics
(VERV)
|
0.5 |
$26M |
|
750k |
34.35 |
Health Catalyst Note 2.500% 4/1 (Principal)
|
0.5 |
$26M |
|
30M |
0.85 |
Molina Healthcare
(MOH)
|
0.5 |
$25M |
|
75k |
329.84 |
Novavax Note 3.750% 2/0 (Principal)
|
0.5 |
$24M |
|
25M |
0.98 |
Springworks Therapeutics
(SWTX)
|
0.5 |
$23M |
|
817k |
28.53 |
Tarsus Pharmaceuticals
(TARS)
|
0.5 |
$23M |
|
1.3M |
17.12 |
Alphatec Hldgs Com New
(ATEC)
|
0.4 |
$22M |
|
2.5M |
8.74 |
Insmed Com Par $.01
(INSM)
|
0.4 |
$21M |
|
961k |
21.54 |
Day One Biopharmaceuticals I
(DAWN)
|
0.4 |
$21M |
|
1.0M |
20.03 |
Enhabit Ord
(EHAB)
|
0.4 |
$20M |
|
1.5M |
14.04 |
Vigil Neuroscience
(VIGL)
|
0.4 |
$18M |
|
2.1M |
8.74 |
Singular Genomics Systems In
|
0.4 |
$18M |
|
7.1M |
2.50 |
Xeris Biopharma Holdings Note 5.000% 7/1 (Principal)
|
0.3 |
$17M |
|
18M |
0.97 |
Tg Therapeutics
(TGTX)
|
0.3 |
$16M |
|
2.7M |
5.92 |
Da32 Life Scnce Tec Acqstn C Class A Com
|
0.3 |
$16M |
|
1.6M |
9.73 |
Oncology Institu
(TOI)
|
0.3 |
$16M |
|
3.4M |
4.63 |
Pacira Pharmaceuticals
(PCRX)
|
0.3 |
$16M |
|
292k |
53.19 |
Sema4 Holdings Corp Com Cl A
|
0.3 |
$15M |
|
17M |
0.88 |
Rocket Pharmaceuticals
(RCKT)
|
0.3 |
$14M |
|
870k |
15.96 |
An2 Therapeutics
(ANTX)
|
0.2 |
$13M |
|
717k |
17.38 |
Krystal Biotech
(KRYS)
|
0.2 |
$12M |
|
175k |
69.70 |
Pacific Biosciences of California
(PACB)
|
0.2 |
$12M |
|
2.0M |
5.80 |
Adc Therapeutics Sa SHS
(ADCT)
|
0.2 |
$12M |
|
2.4M |
4.82 |
Vericel
(VCEL)
|
0.2 |
$11M |
|
485k |
23.20 |
Terns Pharmaceuticals
(TERN)
|
0.2 |
$11M |
|
1.9M |
5.89 |
Eucrates Biomedical Acquisit SHS
|
0.2 |
$10M |
|
1000k |
10.02 |
Sarissa Capital Acquisitn Cl A
|
0.2 |
$10M |
|
1000k |
10.00 |
Alector
(ALEC)
|
0.2 |
$10M |
|
1.1M |
9.46 |
Senior Connect Acquisitn Cor Com Cl A
|
0.2 |
$9.9M |
|
1.0M |
9.95 |
Medtech Acquisition Corp Com Cl A
|
0.2 |
$9.9M |
|
1000k |
9.93 |
Revolution Healthcar Aq Corp Class A Com
|
0.2 |
$9.8M |
|
1.0M |
9.82 |
Apollo Endosurgery
|
0.2 |
$9.6M |
|
1.8M |
5.51 |
Pharvaris N V
(PHVS)
|
0.2 |
$8.5M |
|
1.1M |
7.67 |
Point Biopharma Global
|
0.2 |
$7.7M |
|
1.0M |
7.73 |
Turmeric Acquisition Corp Cl A
|
0.1 |
$7.5M |
|
750k |
10.00 |
Ignyte Acquisition Corp
|
0.1 |
$7.2M |
|
725k |
9.98 |
Pepgen
(PEPG)
|
0.1 |
$6.8M |
|
745k |
9.08 |
Foghorn Therapeutics
(FHTX)
|
0.1 |
$6.7M |
|
778k |
8.58 |
Inozyme Pharma
(INZY)
|
0.1 |
$5.6M |
|
2.1M |
2.68 |
Neogenomics Note 1.250% 5/0 (Principal)
|
0.1 |
$5.6M |
|
6.5M |
0.86 |
Graybug Vision Common
|
0.1 |
$5.0M |
|
5.3M |
0.94 |
Orion Acquisition Corp Com Cl A
|
0.1 |
$4.9M |
|
500k |
9.85 |
Werewolf Therapeutics
(HOWL)
|
0.1 |
$4.3M |
|
958k |
4.51 |
Quantum Si Com Cl A
(QSI)
|
0.1 |
$3.9M |
|
1.4M |
2.75 |
Annexon
(ANNX)
|
0.1 |
$3.6M |
|
584k |
6.18 |
Orchard Therapeutics Spon Ads
|
0.1 |
$3.5M |
|
6.9M |
0.50 |
Kinnate Biopharma
|
0.1 |
$3.0M |
|
250k |
11.95 |
Profound Med Corp Com New
(PROF)
|
0.1 |
$3.0M |
|
733k |
4.04 |
Nyxoah S A SHS
(NYXH)
|
0.1 |
$2.9M |
|
455k |
6.30 |
Oncorus
|
0.1 |
$2.7M |
|
3.1M |
0.85 |
Acutus Medical
(AFIB)
|
0.0 |
$2.3M |
|
2.7M |
0.88 |
Delcath Sys Com New
(DCTH)
|
0.0 |
$1.6M |
|
486k |
3.20 |
Caremax *w Exp 06/08/202
(CMAXW)
|
0.0 |
$1.3M |
|
672k |
1.88 |
The Oncology Institute *w Exp 11/15/202
(TOIIW)
|
0.0 |
$691k |
|
1.3M |
0.55 |
Medavail Holdings Ord
|
0.0 |
$649k |
|
837k |
0.78 |
Butterfly Network *w Exp 02/12/202
(BFLY.WS)
|
0.0 |
$616k |
|
733k |
0.84 |
Nuvation Bio Com Cl A
(NUVB)
|
0.0 |
$550k |
|
245k |
2.24 |
Roivant Sciences *w Exp 09/30/202
|
0.0 |
$390k |
|
1.0M |
0.39 |
Cabaletta Bio
(CABA)
|
0.0 |
$302k |
|
464k |
0.65 |
Quantum Si *w Exp 06/10/202
(QSIAW)
|
0.0 |
$177k |
|
333k |
0.53 |
Somalogic *w Exp 08/31/202
|
0.0 |
$53k |
|
120k |
0.44 |
Ignyte Acquisition Corp *w Exp 01/05/202
|
0.0 |
$45k |
|
363k |
0.12 |
Nuvation Bio *w Exp 07/07/202
(NUVB.WS)
|
0.0 |
$33k |
|
167k |
0.20 |
Surrozen *w Exp 08/01/203
(SRZNW)
|
0.0 |
$31k |
|
167k |
0.19 |
Medtech Acquisition Corp *w Exp 12/22/202
|
0.0 |
$20k |
|
333k |
0.06 |
Eucrates Biomedical Acqu Cor *w Exp 10/23/202
|
0.0 |
$13k |
|
333k |
0.04 |
Senior Connect Acquisitn Cor *w Exp 12/31/202
|
0.0 |
$10k |
|
500k |
0.02 |
Revolution Healthcar Aq Corp *w Exp 12/31/202
|
0.0 |
$9.0k |
|
200k |
0.04 |
Turmeric Acquisition Corp *w Exp 10/08/202
|
0.0 |
$7.0k |
|
250k |
0.03 |
Orion Acquisition Corp *w Exp 02/19/202
|
0.0 |
$7.0k |
|
125k |
0.06 |
Sarissa Capital Acquisitn *w Exp 10/23/202
|
0.0 |
$7.0k |
|
333k |
0.02 |
Windtree Therapeutics
|
0.0 |
$6.0k |
|
20k |
0.30 |
Glaukos
(GKOS)
|
0.0 |
$0 |
|
0 |
0.00 |
Eucrates Biomedical Acqu Cor Unit 10/23/2027
|
0.0 |
$0 |
|
1.00 |
0.00 |
Sarissa Capital Acquisitn Unit 10/23/2027
|
0.0 |
$0 |
|
1.00 |
0.00 |
Medtech Acquisition Corp Unit 12/18/2025
|
0.0 |
$0 |
|
1.00 |
0.00 |